Cardioviruses: Encephalomyocarditis Virus and Theiler's Murine Encephalomyelitis Virus

The Mouse in Biomedical Research

Volumn 2, Issue , 2007, Pages 311-323

  Lipton, Howard L ^a   Manoj Kumar, A S ^a   Hertzler, Shannon ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61849182396     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369454-6/50040-6     Document Type: Chapter

References (120)

1. Aminev A.G., Amineva S.P., Palmenberg A.C. Encephalomy-ocarditis viral protein 2A localizes to nucleoli and inhibits cap-dependent translation. Virus Res 2004, 95:45-57.
2. Aubert C., Chamorro M., Brahic M. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathog 1987, 3:319-326.
3. Batson S., Rundell K. Proteolysis at the 2A/2B junction in Theiler's murine encephalomyelitis virus. Virology 1991, 181:764-767.
4. Begolka W.S., Vanderlugt C.L., Rahbe S.M., Miller S.D. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multi-ple sclerosis. J. Immunol. 1998, 161:4437-4446.
5. Boege U., Kobasa D., Onodera S., Parks G.D., Palmenberg A.C., Scraba D.G. Characterization of Mengo virus neutralization epitopes. Virology 1991, 181:1-13.
6. b molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 1997, 71:5244-5250.
7. Brahic M., Bureau J.-F. Genetics of susceptibility to Theiler's virus infection. BioEssays 1998, 20:627-633.
8. Brownstein D., Bhatt P., Ardito R., Paturzo F., Johnson E. Duration and patterns of transmission of Theiler's mouse encephalomyelitis virus infection. Lab Animal Sci. 1989, 4:299-301.
9. Burch G.E., Tsui C.Y., Harb J.M., Colcolough H.L. Mural and valvular endocarditis of mice infected with encephalomyocarditis (EMC) virus. Exp Molec Pathol 1981, 14:327-336.
10. Bureau J.-F., Montagutelli X., Lefebvre S., Guenet J.L., Pla M., Brahic M. The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system. J Virol 1992, 66:4698-4704.
11. Calisher C.H., Rowe W.P. Mouse hepatitis reo-3 and the Theiler's virus. Natl Cancer Inst Monogr 1966, 20:67-75.
12. Campbell J.B., Buera J.G., Tobias F.M. Influence of blood clear-ance rates on interferon production and virulence of mengo virus plaque mutants in mice. Can J Microbiol 1970, 16:821-826.
13. Casals J. Immunological characterization of Vilyuisk human encephalomyelitis virus. Nature 1963, 200:339-341.
14. Causey O.R., Shope R.E., Laemmert H. Report of an epizootic of encephalomyocarditis virus in Para Brazil. Rev Serv Esp Saude Publica 1962, 12:47-50.
15. Chen H.-H., Kong W.-P., Roos R.P. The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein. J. Virol. 1995, 69:8076-8078.
16. Clatch R.J., Lipton H.L., Miller S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV) -specific delayed-type hypersensi-tivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J. Immunol. 1986, 136:920-926.
17. Clatch R.J., Melvold R.W., Miller S.D., Lipton H.L. Theiler's murine encephalomyelitis virus (TMEV) -induced demyeli-nating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 1985, 135:1408-1414.
18. Craighead J.E. Pathogenicity of M and E variants of the encephalomy-ocarditis (EMC) virus. I. Myocardiotropic and neurotropic properties. Am J Pathol 1966, 48:333-345.
19. Craighead J.E., McClane M.F. Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 1968, 162:913-914.
20. Daniels J.B., Pappenheimer A.M., Richardson S. Observations on encephalomyelitis of mice (DA strain). J Exp Med 1952, 96:517-530.
21. Dean D.J. Mouse encephalomyelitis. Immunological studies of a non-infected colony. J. Immunol. 1951, 66:347-359.
22. Delhaye S., van Pesch V., Michiels T. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 2004, 78:4357-4362.
23. Descoteaux J.-P., Grignon-Archambault D., Lussier G. Serologic study on the prevalence of murine viruses in five Canadian mouse colonies. Lab Animal Sci 1977, 27:621-626.
24. Dethlefs S., Brahic M., Larsson-Sciard E.-L. An early abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for pre-venting viral persistence. J. Virol. 1997, 71:8875-8878.
25. Dethlefs S., Escriou N., Brahic M., van der Werf S., Larsson-Sciard E.-L. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J Virol 1997, 71:5361-5365.
26. Dick G.W.A. The relationship of Mengo encephalomyelitis encephalomy-ocarditis Columbia-S.K. and MM viruses. J Immunol 1949, 62:375-386.
27. Dick G.W.A., Smithburn K.C., Haddow A.J. Mengo encephalomyelitis virus isolation and immunological properties. Brit J Exp Pathol 1948, 29:547-558.
28. Duke G.M., Osorio J.E., Palmenberg A.C. Attenuation of Mengo virus through genetic engineering of the 5 prime; noncoding poly (C) tract. Nature 1990, 343:474-476.
29. Dvorak C.M., Hall D.J., Riddle M., et al. Leader protein of encephalomyocarditis virus binds zinc is phosphorylated during viral infec-tion and affects the efficiency of genome translation. Virology 2001, 290:261-271.
30. Feltz E.T., Mandel B., Racker E. Susceptibility of mice free of Theiler's virus (TO strain) to infection with TO virus. J Exp Med 1953, 98:427-432.
31. Fotiadis C., Kilpatrick D.R., Lipton H.L. Comparison of the binding characteristics to BHK-21 cells of viruses representing the two Theiler's virus neurovirulence groups. Virology 1991, 182:365-370.
32. Friedman R., Maenza R.M. Peroral infection and resistance to reinfection with encephalomyocarditis virus in mice. J Infect Dis 1968, 118:125-134.
33. Friedmann A., Lipton H.L. Replication of GDVII and DA strains of Theiler's murine encephalomyelitis virus in BHK 21 cells: an electron microscopic study. Virology 1980, 101:389-398.
34. Gard S. Observations concerning the pathogenesis and epidemiology of mouse poliomyelitis. Yale J. Biol. Med 1944, 16:467-476.
35. Gerety S.J., Karpus W.J., Cubbon A.R., et al. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinat-ing disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J Immunol 1994, 152:908-918.
36. + T cell line specific for an immunodominant VP2 epitope. J Immunol 1994, 152:919-929.
37. Grant R.A., Filman D.J., Fujinami R.S., Icenogle J.P., Hogle J.M. Three-dimensional structure of Theiler's virus. Proc Natl Acad Sci USA 1992, 89:2061-2065.
38. Hahn H., Palmenberg A.C. Mutational analysis of the encephalomyocarditis virus primary cleavage. J Virol 1996, 70:6875.
39. Helwig F.C., Schmidt E.C.H. A filter-passing agent producing interstitial myocarditis in anthropoid apes and small animals. Science 1945, 102:31-33.
40. Hemelt I.R., Huxsoll D.L., Warner A.R. Comparison of MHG virus with mouse encephalomyelitis viruses. Lab Animal Sci 1974, 24:523-529.
41. Huber S.A. VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells. J Virol 1994, 68:3453-3458.
42. Jang S.K., Krausslich H.G., Nicklin M.J.H., Duke G.M., Palmenberg A.C., Wimmer E. A segment of the 5 prime; nontranslated region of encephalomyocarditis RNA directs internal entry of ribosomes during in vitro translation. J Virol 1988, 62:2636-2643.
43. Jarousse N., Viktorova E.G., Pilipenko E.V., Agol V.I., Brahic M. An attenuated variant of the GDVII strain of Theiler's virus does not persist and does not infect the white matter of the central nervous system. J Virol 1999, 73:801-804.
44. Jelachich M.L., Bandyopadhyay P., Blum K., Lipton H.L. Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation. Virology 1995, 209:437-444.
45. Jelachich M.L., Lipton H.L. Restricted Theiler's murine encephalomyelitis virus infection in murine macrophages induces apoptosis. J Gen Virol 1999, 80:1701-1705.
46. Jelachich M.L., Lipton H.L. Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis. J Virol 1996, 70:6856-6861.
47. Jungeblut C.W., Dalidorf G. Epidemiological and experimental observations on the possible significance of rodents in a suburban epidemic of poliomyelitis. Am J Public Health 1943, 33:169-172.
48. + T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional. J Virol 2002, 76:6577-6585.
49. + subset. Multiple Sclerosis 2002, 8:469-474.
50. Kerr J.A. Studies on certain viruses isolated in the tropics of Africa and South America. Immunological reactions as determined by cross comple-ment fixation tests. J. Immunol. 1952, 68:461-472.
51. Kilham L., Mason P., Davies J.N.P. Host-virus relations in encephalomyelitis (EMC) virus infections. I. Infections of wild rats. Am J Trop Med Hyg 1956, 5:647-663.
52. Kilham L., Mason P., Davies J.N.P. Pathogenesis of fatal encephalomyelitis (EMC) virus infec-tions in albino rats. Proc Soc Exp Biol. Med 1955, 90:383-387.
53. Kilpatrick D.R., Lipton H.L. Predominant binding of Theiler's viruses to a 34-kilodalton receptor protein on susceptible cell lines. J Virol 1991, 65:5244-5249.
54. Knowles N.J., Dickinson N.D., Wilsden G., Carra E., Brocchi E., De Simone F. Molecular analysis of encephalomyocarditis virus isolated from pigs and rodents in Italy. Virus Res 1998, 57:53-62.
55. Kobasa D., Mulvey M., Lee J.S., Scraba D.G. Characterization of Mengo virus neutralization epitopes. II. Infection of mice with an attenu-ated virus. Virology 1995, 214:118-127.
56. Kong W.-P., Ghadge G.D., Roos R.P. Involvement of cardiovirus leader in host cell-restricted virus expression. Proc Natl Acad Sci USA 1994, 91:1796-1800.
57. Lehrich J.R., Arnason B.G.W., Hochberg F.H. Demyelinating myelopathy in mice induced by the DA virus. J Neurol Sci 1976, 29:149-160.
58. Levy M., Aubert C., Brahic M. Theiler's virus replication in brain macrophages cultured in vitro. J Virol 1992, 66:3188-3193.
59. Lipton H.L. Characterization of the TO strains of Theiler's mouse encephalomyelitis viruses. Infect Immun 1978, 20:869-872.
60. Lipton H.L. Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect Immun 1975, 11:1147-1155.
61. Lipton H.L., Kim B.S., Yahikozawa H., Nadler C.F. Serological evidence that Mus musculus is the natural host of Theiler's murine encephalomyelitis virus. Virus Res 2001, 76:79-86.
62. Lipton H.L., Melvold R. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J Immunol 1984, 132:1821-1825.
63. Lipton H.L., Pritchard A.E., Bandyopadhyay P.K., Calenoff M.A. Theiler's murine encephalomyelitis virus (TMEV) strain GDVII strain does not contain a determinant for central nervous system persistence. J Gen Virol 1998, 79:1001-1004.
64. Lipton H.L., Twaddle G., Jelachich M.L. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus (TMEV) -induced demyelinating disease. J Virol 1995, 69:2525-2533.
65. Luo M., He C., Toth K.S., Zhang C.X., Lipton H.L. Three-dimensional structure of Theiler's murine encephalomyelitis virus (BeAn strain). Proc Natl Acad Sci USA 1992, 89:2409-2413.
66. Luo M., Toth K.S., Zhou L., Pritchard A., Lipton H.L. The struc-ture of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology 1996, 220:246-250.
67. Luo M., Vriend G., Kamer G., et al. The atomic structure of Mengo Virus at 3.0 A resolution. Science 1987, 235:182-191.
68. + T cell responses in Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J mice. Eur J Immunol 2004, 34:2730-2739.
69. Martinat C., Jarousse N., Prevost M.-C., Brahic M. The GDVII strain of Theiler's virus spreads via axonal transport. J Virol 1999, 73:6093-6098.
70. Melnick J.L., Riordan J.T. Latent mouse encephalomyelitis. J Immunol 1947, 57:331-342.
71. Melvold R.W., Miller S.D Immunogenetics resistance and suscep- tibility to TMEV infection. Experimental models of multiple sclerosis 2005, 629-644. Springer, New York. E. Lavi, C.S. Constantiecu (Eds.).
72. + T cell response against a single immunodominant viral peptide. Eur J Immunol 2003, 33:2501-2510.
73. Murnane T.G., Craighead J.E., Mondragon H., Shelokov A. Fatal disease of swine due to encephalomyocarditis virus. Science 1960, 131:498-499.
74. + T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. J Immunol 1996, 156:1276-1283.
75. Nicholson S.M., Peterson J.D., Miller S.D., Wang K., Dal Canto M.C., Melvold R.W. BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neuroimmunol 1994, 52:19-24.
76. Nitayaphan S., Toth M.M., Roos R.P Localization of a neuraliza-tion site of Theiler's murine encephalomyelitis viruses. J Virol 1985, 56:887-895.
77. Nitayaphan S., Toth M.M., Roos R.P. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis virus. J Virol 1985, 53:651-657.
78. Njenga M.K., Asakura K., Hunter S.F., Wettstein P., Pease L.R., Rodriguez M. The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J Virol 1997, 71:8592-8601.
79. Notkins A.L. Virus-induced diabetes mellitus. Arch Virol 1977, 54:1-17.
80. Obuchi M., Ohara Y., Takegami T., Murayama T., Takada H., Iizuka H. Theiler's murine encephalomyelitis virus subgroup strain-specific infection in a murine macrophage-like cell line. J Virol 1997, 71:729-733.
81. Ohara Y., Stein S., Fu J., Stillman L., Klaman L., Roos R.P. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis virus. Virology 1988, 164:245-255.
82. Ohsawa K., Watanabe Y., Miyata H., Sato H. Genetic analysis of a Theiler-like virus isolated from rats. Comp Med 2003, 53:44-49.
83. Olitsky P.K. Further studies of the agent in the intestines of normal mice which induces encephalomyelitis. Proc Soc Exp Biol Med 1940, 43:296-300.
84. Olitsky P.K. Viral effect produced by intestinal contents of normal mice and those having spontaneous encephalomyelitis. Proc Soc Exp Biol Med 1939, 43:434-437.
85. Palmenberg A.C., Osorio J.E. Cardioviral poly (C) tracts and viral pathogenesis. Arch Virol 1994, 9:67-77.
86. Pena-Rossi C., Delcroix M., Huitinga I., et al. Role of macrophages during Theiler's virus infection. J Virol 1997, 71:3336-3340.
87. Peterson J.D., Waltenbaugh C., Miller S.D. IgG subclass responses to Theiler's murine encephalomyelitis virus infection and immu-nization suggest a dominant role for Th1 cells in susceptible mouse strains. Immunology 1992, 75:652-658.
88. Pevear D.C., Calenoff M., Rozhon E., Lipton H.L. Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol 1987, 61:1507-1516.
89. Pilipenko E.V., Viktorova E.G., Khitrina E.V., et al. Distinct attenua-tion phenotypes caused by mutations in the translational starting window of Theiler's murine encephalomyelitis virus. J Virol 1999, 73:3190-3196.
90. Reddi H.V., Lipton H.L. Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses. J Virol 2002, 76:8400-8407.
91. Rodriguez M., Leibowitz J., David C.S. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med 1986, 163:620-631.
92. Rossmann M.G., He Y., Kuhn R.J. Picornavirus-receptor inter-actions. Trends Microbiol 2002, 10:324-331.
93. Rozengurt N., Sanchez S. A spontaneous outbreak of Theiler's encephalomyelitis in a colony of severe combined immunodeficient mice in the UK. Lab Animals 1993, 27:229-234.
94. Rozhon E.J., Kratochvil J.D., Lipton H.L. Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system. Virology 1983, 128:16-32.
95. Rueckert R.R., Wimmer E. Systematic nomenclature of picor-naviral proteins. J Virol 1984, 50:957-959.
96. Sangar D.V., Rowlands D.J., Brown F. Encephalomyocarditis virus antibodies in sera from apparently normal pigs. Vet Record 1977, 100:240-241.
97. Sato S., Zhang L., Kim J., et al. A neutralization site of DA strain of Theiler's murine encephalomyelitis virus important for disease phenotype. Virology 1996, 226:327-337.
98. Shah A.H., Lipton H.L. Low-neurovirulence Theiler's viruses use sialic acid moieties on N-linked oligosaccharide structures for attachment. Virology 2002, 304:443-450.
99. Shaw M. Serologic studies of Theiler's encephalomyelitis virus. Proc Soc Exp Biol. Med 1956, 92:390-392.
100. Simas J.P., Dyson H., Fazakerley J.K. The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells. J Virol 1995, 69:5599-5606.
101. Smith A.L., Singleton G.R., Hansen G.M., Shellam G. A serologic survey for viruses and Mycoplasma pulmonis among wild house mice (Mus domesticus) in south eastern Australia. J Wildlife Dis 1993, 29:219-229.
102. Spier R.W. pH and thermal stability of mengovirus. Virology 1962, 17:588-592.
103. Spier R.W, Aliminosa K.V, Southam C.M. Differences in infec-tivity of neurotropic viruses incubated in distilled water isotonic NaCl and hypertonic NaCl. Proc Soc Exp Biol. Med 1962, 109:80-82.
104. Tesh R.B., Wallace G.B. Observations on the natural history of encephalomyocarditis virus. Am J Trop Med Hyg 1978, 27:133-143.
105. Theiler M. Spontaneous encephalomyelitis of mice-a new virus dis-ease. Science 1934, 80:122.
106. Theiler M. Spontaneous encephalomyelitis of mice a new virus disease. J Exp Med 1937, 65:705-719.
107. Theiler M. Studies on poliomyelitis. Medicine 1941, 20:443-462.
108. Theiler M., Gard S. Encephalomyelitis of mice. I. Characteristics and pathogenesis of the virus. J Exp Med 1940, 72:49-67.
109. Theiler M., Gard S. Encephalomyelitis of mice. II. Epidemiology. J Exp. Med 1940, 72:79-90.
110. Thompson R., Harrison W.M., Meyer F.P. A spontaneous epi-zootic of mouse encephalomyelitis. Proc Soc Exp Biol. Med 1951, 11:262-266.
111. Trottier M., Kallio P., Wang W., Lipton H.L. High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus. J Virol 2001, 75:7428.
112. Trottier M., Schlitt B.P., Kung A.Y, Lipton H.L. Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease. J Virol 2004, 78:12480-12488.
113. Vanella J., Kissling R.E., Chamberlain R.W. Transmission stud-ies with encephalomyocarditis virus. J Infect Dis 1956, 98:98-102.
114. van Pesch V., van Eyll O., Michiels T. The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon. J Virol 2001, 75:7811-7817.
115. Warren J., Russ S.B., Jeffries H. Neutralizing antibody against viruses of the encephalomyocarditis group in the sera of wild rats. Proc Soc Exp Biol. Med 1949, 71:376-378.
116. Wroblewska Z., Gilden D.H., Wellish M., Rorke L.B., Warren K.G., Wolinsky J.S. Virus-specific intracytoplasmic inclusions in mouse brain produced by a newly isolated strain of Theiler's virus. I. Virologic and morphologic studies. Lab Invest 1977, 37:595-602.
117. Yauch R.L., Kerekes K., Saujani K., Kim B.S. Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice. J Virol 1995, 69:7315-7318.
118. 233-244. J Immunol 1994, 153:4508-4519.
119. Zoll J., Melchers W.J.G., Galama J.M.D., van Kuppevold F.J.M. The Mengovirus leader protein suppresses alpha/beta interferon production by inhibition of the iron/ferritin-mediated activation of NF-kB. J Virol 2002, 76:9664-9672.
120. Zurbriggen A., Fujinami R.S. A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central ner-vous system. J Virol 1989, 63:1505-1513.